2. ● Tripronuclear (3PN) zygotes have one oocyte nucleus and two sperm
nuclei.
● Discarded in clinics, during in vitro fertilization (IVF) clinical trials
● In this study, Tripronuclear (3PN) zygotes are used to investigate
CRISPR/Cas9-mediated gene editing in human cells.
● Used because of ethical concerns regarding gene editing in normal
embryos
● Ideal model system to examine the targeting efficiency and off-target
effects of CRISPR/Cas9 during early human embryonic development
Dispermy
3. Components
- gRNA: guide RNA, used to direct the
Cas9 protein to bind and cleave a
particular DNA sequence for genome
editing
- Cas: CRISPR-associated System,
endonuclease protein; able to cleave
nucleic acid.
- *PAM: protospacer adjacent motif, a short
specific sequence, essential for cleavage
by Cas endonuclease
*NHEJ: Non-Homologous End Joining
4. Objective: To cleave and repair HBB gene coding for protein Hemoglobin
using CRISPR/Cas9 system - can be used to correct mutations which leads
to disorders such as 𝛃-thalassemia.
* 𝛃-thalassemia is a genetic blood disorder (inability to produce RBC)
Application: CRISPR can efficiently cleave the
endogenous gene in human tripronuclear zygotes
(3PN) resulting in double strand break (DSB) which can
be repaired by non-homologous end joining (NHEJ)
and homologous recombination directed repair (HDR).
6. A)DSBs may be repaired
through the double-
strand break repair (DSBR)
pathway or the non-
crossover synthesis-
dependent strand
annealing (SDSA) pathway
B)The HBD locus from the
7 recombined 3PN
embryos were similarly
examined as above.*
Indicates that the HBD
locus failed to be
amplified in two of the
embryos.
C)Repair of DSBs
generated by
CRISPR/Cas9 occurs
mainly through NHEJ.
If HDR is utilized, the
non-crossover
pathway is preferred.
7. - Of the 54 PCR-amplified embryos, 28 were cleaved by Cas9, indicating
an efficiency of ∼52%
- 4 of the 28 Cas9-cleaved embryos (14.3%) were clearly edited using the
ssDNA oligo as a repair template
- 7 out of the 28 cleaved embryos (25%) shows recombination of the HBB
gene with HBD , even in the presence of co-injected exogenous ssDNA
donor template
8. Advantage Limitation
- Increased Experimental
Convenience
- Less ethical concern as
3PN are discarded in
clinics anyway
- Used as an alternative to
normal human zygote
- Off-target changes leading
to unintended mutations
- Difficult to apply RNA
polymerase Ⅱ for gRNA
production
- Efficiency of delivery
method depends on the
type of target cells/tissues
9. Current developments
● Clinical applications are premature
● Introduction of a naturally occurring allele into early human 3PN
zygotes (Fan, 2016).
Future perspectives
● Need to improve the specificity and accuracy before proceeding to
clinical applications
● Need to understand the mechanisms more comprehensively
● Genetic mutations can be corrected in early embryos at a premature
stage (developing treatments for genetic disorders)
10. Reference
Liang, P., Xu, Y., Zhang, X., Ding, C., Huang, R., Zhang, Z., Lv, J.,
Xie, X., Chen, Y., Li, Y., Sun, Y., Bai, Y., Songyang, Z., Ma, W.,
Zhou, C. and Huang, J. (2015). CRISPR/Cas9-mediated gene
editing in human tripronuclear zygotes. Protein & Cell, 6(5),
pp.363-372.
Kang, X., He, W., Huang, Y., Yu,. Chen, Y., Gao, X., Sun, X., Fan,
Y. (2016). Introducing precise genetic modifications into
human 3PN embryos by CRISPR/Cas9-mediated genome
editing. J Assist Reprod Genet, 33(5), pp. 581-588
Editor's Notes
- construction and use of CRISPR plasmids
- identification and collection of 3PN embryos
- embryo vitrification and recovery
- analysis of CRISPR/Cas9 induced cleavages ( Five embryos with double peaks near the PAM sequence were randomly selected for the T7E1 assay)
- Whole genome amplification using Embryos
Whole-exome sequencing, data processing, and off-target analysis
Whole-exome sequencing, data processing & off target analysis: exome sequenced on illumina HiSeq 2000 PE100 (Whole-exome sequencing is a widely used next-generation sequencing (NGS) method that involves sequencing the protein-coding regions of the genome.)
three gRNAs (named G1, G2, and G3) that targeted different regions of the HBB gene, transfected the gRNA-Cas9 expression vectors into human 293T cells
Sequencing analysis of the two regions targeted by G1 and G2 revealed distinct indel spectra, reflecting different NHEJ repair preferences at these two sites
7 recombined 3PN embryos were amplified and examined, we found that the HBD locus in the 5 successfully-amplified embryos remained intact, containing no HBB sequences
results suggest that homologous recombination in human early embryos preferentially occur through the non-crossover HDR pathway
In human embryos, repair of DSBs generated by CRISPR/Cas9 occurs mainly through NHEJ.
Since it is a precise genome editing tool, it increased the experimental convenience
Although some ethical concerns arose regarding this experiment, using 3PN are less ethical since they are discarded in IVF clinics anyway.
3PNs can be used as an alternative to normal human zygotes
Limitations
During this study, off target changes were detected, which lead to unwanted mutations
Due to extensive posttranscriptional processing and modification of mRNA transcribed by RNA polymerase II, it is currently difficult to apply RNA polymerase II for gRNA production.
Efficiency of delivery methods of CRISPR depends on the type of target cells or tissues
The clinical applications of CRISPR/Cas9 mediated genome editing in human embryos is still premature at this stage
This study was done in 2015, and in 2016, a couple of scientists successfully introduced a naturally occurring allele into an early human tripronuclear zygotes
Due to the mosaicism and mutations at non targeted site, we Need to improve the specificity and accuracy of CRISPR/Cas9 system before proceeding to this technique-mediated clinical applications
We need to more comprehensively understand the mechanisms of CRISPR/Cas9-mediated genome editing in human cells
Using these principles, in the future, genetic mutations can be corrected in an early embryonic premature stage, enhancing treatments for genetic disorders
Because the edited embryos are genetically mosaic, it would be impossible to predict gene editing outcomes through pre-implantation genetic diagnosis (PGD)..